copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Paul-Louis BELLETANTE - Founder CEO I Boli Care | LinkedIn Founder amp; CEO I Boli Care · Founder, Boli Care - a digital therapeutic supporting GLP‑1 treatment and driving long-term metabolic outcomes Starting September 2025 - lean by design, global by ambition, patient-led by conviction Father of two, I’m a digital health entrepreneur based in Biarritz, France — passionate about using science, tech and empathy to improve lives After
Boli - Digital Therapeutic for GLP-1, Obesity Diabetes - Team - boli. care Combining entrepreneurial agility with clinical-grade execution, our leadership team has built and scaled digital therapeutics platforms globally – driving adoption through B2B and B2C channels, from health plans to direct-to-patient models
Paul-Louis Belletante - MedTech Meetup France Paul-Louis Belletante Co-Fondateur et CEO, Boli Care Paul-Louis est le co-fondateur et CEO de Boli Care Fondée en 2025, Boli Care intervient dans le champ de l’obésité et de la santé métabolique La société accompagne les patients dès l’initiation des traitements GLP‑1 (Ozempic, Wegovy, Mounjaro), avec un objectif clair : les aider à atteindre une santé métabolique durable
Paul-Louis BELLETANTE’s Post - LinkedIn Boli Care is built to do just that — → for patients → for healthcare systems → and for every partner looking to make a real-world difference 📊 Source in comments cc Edouard Martinet
Boli Care - October 25 | Boli Care - LinkedIn 🎯 October at Boli — A month of momentum Obesity is complex Metabolic health deserves more than medication At Boli, we’re building a smarter, more supportive path — and we’re moving
Boli Care - LinkedIn Boli Care | 359 abonnés sur LinkedIn A new era in obesity and diabetes digital care From GLP-1 support to sustainable metabolic health | Boli is building the first AI-native companion for patients on GLP‑1 treatment — for obesity and type 2 diabetes GLP‑1 medications are reshaping the future of metabolic care, unlocking a $200B market But drugs alone aren’t enough
WARNING: On Thanksgiving, AMP Turns Chicago into the Command Center for . . . On Thanksgiving, American Muslims for Palestine is assembling the surviving infrastructure of the U S Muslim Brotherhood in Chicago for the largest anti-Western conference in America, bringing together Hamas-linked operatives, campus agitators, political radicals, and youth indoctrination programs to advance an ideological war against the United States